REFERENCES
- MacKay A, Al-Haddad M: Acute lung injury. Anaesth Intens Care Med. 2010;11:487–489.
- Matthay MA, Zemans RL: The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–163.
- Xu CM, Chen HL: Research advance in CD147 and acute lung injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25:765–768.
- Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet. 1967;2:319–323.
- Favarin DC, de Oliveira JR, de Oliveira CJ, Rogerio Ade P: Potential effects of medicinal plants and secondary metabolites on acute lung injury. Biomed Res Int. 2013;2013:576479.
- Sweatt AJ, Levitt JE: Evolving epidemiology and definitions of the acute respiratory distress syndrome and early acute lung injury. Clin Chest Med. 2014;35:609–624.
- Bastarache JA, Sebag SC, Grove BS, Ware LB: Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res. 2011;37:509–517.
- Devaraj D, Srisakthi D: Hyperbaric oxygen therapy-can it be the new era in dentistry? J Clin Diagn Res. 2014;8:263–265.
- Ye X, Zhang J, Lu R, Zhou G: HBO: a possible supplementary therapy for oral potentially malignant disorders. Med Hypotheses. 2014;83:131–136.
- Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S et al.: Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol. 1997;17:154–159.
- Bedioui H, Makni A, Magherbi H, Ben Safta Z: Hyperbaric oxygen in the treatment of perineal Crohn's disease era of infliximab: a renewal interest? Tunis Med. 2012;90: 427–430.
- Ding Z, Tong WC, Lu XX, Peng HP: Hyperbaric oxygen therapy in acute ischemic stroke: a review. Interv Neurol. 2014;2:201–211.
- Moen I, Stuhr LE: Hyperbaric oxygen therapy and cancer-a review. Target Oncol. 2012;7:233–242.
- Nasole E, Nicoletti C, Yang ZJ, Girelli A, Rubini A, Giuffreda F et al.: Effects of alpha lipoic acid and its R+ enantiomer supplemented to hyperbaric oxygen therapy on interleukin-6, TNF-α and EGF production in chronic leg wound healing. J Enzyme Inhib Med Chem. 2014;29:297–302.
- Lu MY, Kang BH, Wan FJ, Chen CS, Huang KL: Hyperbaric oxygen attenuates lipopolysaccharide-induced acute lung injury. Intensive Care Med. 2002;28:636–641.
- Pan AJ, Jin K, Zhou SS, Li C, Shen JJ, Liu B: Effects of hyperbaric oxygen on the acute lung injury induced by oleic acid in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;22:422–425.
- Bozok S, Ilhan G, Yilmaz Y, Dökümcü Z, Tumkaya L, Karamustafa H et al.: Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model. Eur J Med Res. 2012;17:14.
- Chu SJ, Li MH, Hsu CW, Tsai SH, Lin SH, Huang KL: Influence of hyperbaric oxygen on tumor necrosis factor-alpha and nitric oxide production in endotoxin-induced acute lung injury in rats. Pulm Pharmacol Ther. 2007;20: 684–690.
- Huang TY, Tsai PS, Wang TY, Huang CL, Huang CJ: Hyperbaric oxygen attenuation of lipopolysaccharide-induced acute lung injury involves heme oxygenase-1. Acta Anaesthesiol Scand. 2005;49:1293–1301.
- Feng Y, Zhang Z, Li Q, Li W, Xu J, Cao H: Hyperbaric oxygen preconditioning protects lung against hyperoxic acute lung injury in rats via heme oxygenase-1 induction. Biochem Biophys Res Commun. 2014;456:549–554. http://dx.doi.org/ 10.1016/j.bbrc.2014.09.074.
- Burghardt B, Elkaer ML, Kwon TH, Rácz GZ, Varga G, Steward MC et al.: Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut. 2003;52:1008–1016.
- Matsuzaki T, Hata H, Ozawa H, Takata K: Immunohistochemical localization of the aquaporins AQP1, AQP3, AQP4, and AQP5 in the mouse respiratory system. Acta Histochem Cytochem. 2009;42:159–169.
- Liu S, Zhang S, Jiang H, Yang Y, Jiang Y: Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis. Med Oncol. 2013;30:636.
- Shan T, Cui X, Li W, Lin W, Li Y: AQP5: a novel biomarker that predicts poor clinical outcome in colorectal cancer. Oncol Rep. 2014;32:1564–1570.
- Rubenwolf PC, Otto W, Denzinger S, Hofstädter F, Wieland W, Georgopoulos NT: Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage. World J Urol. 2014;32:991–997.
- Jin Y, Yu G, Peng P, Zhang Y, Xin X: Down-regulated expression of AQP5 on lung in rat DIC model induced by LPS and its effect on the development of pulmonary edema. Pulm Pharmacol Ther. 2013;26:661–665.
- Jiao G, Li E, Yu R: Decreased expression of AQP1 and AQP5 in acute injured lungs in rats. Chin Med J (Engl). 2002;115:963–967.
- Zhang Y, Chen M, Zhang Y, Peng P, Li J, Xin X: miR-96 and miR-330 overexpressed and targeted AQP5 in lipopolysaccharide-induced rat lung damage of disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2014;25: 731–737.
- Dong C, Wang G, Li B, Xiao K, Ma Z, Huang H et al.: Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. Respir Physiol Neurobiol. 2012;181:21–28.
- Yan W, Jiang H, Chen W: Study on lipopolysaccharide(LPS)-induced aspiration lung injury in rats. J Tissue Eng Reconstruct Surg. 2010;6:96–100.
- Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al.: Report of the American European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med. 1994;20:225–232.
- Shaver CM, Bastarache JA: Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury. Clin Chest Med. 2014;35:639–653.
- Tamura DY, Moore EE, Partrick DA, Johnson JL, Offner PJ, Silliman CC: Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock. 2002;17:269–273.
- Perng WC, Wu CP, Chu SJ, Kang BH, Huang KL: Effect of hyperbaric oxygen on endotoxin-induced lung injury in rats. Shock. 2004;21:370–375.